Sign In
Buy BSEM
$4.14
-0.0290 (-0.696%)
At Close: Jun 03, 2026
BioStem Technologies Appoints KPMG as its Independent Registered Public Accountant
04:15pm, Monday, 27'th Oct 2025
POMPANO BEACH, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (the “Company”), a leading MedTech company focused on the development, manufacturing, and commercializ
BioStem Technologies Appoints KPMG as its Independent Registered Public Accountant
04:14pm, Monday, 27'th Oct 2025
POMPANO BEACH, FL, October 27, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies, Inc.
BioStem Technologies Expands Partnership with the Florida Panthers as a Sponsor for the 13th Season of the “Heroes Among Us” Program
12:02pm, Thursday, 02'nd Oct 2025
Program has honored more than 500 members of the military since its inception Sponsorship honors both local military veterans and healthcare professionals POMPANO BEACH, Fla., October 2, 2025 – PRIS
BioStem Technologies Expands Partnership with the Florida Panthers as a Sponsor for the 13th Season of the “Heroes Among Us” Program
12:00pm, Thursday, 02'nd Oct 2025
Program has honored more than 500 members of the military since its inception Sponsorship honors both local military veterans and healthcare professionals POMPANO BEACH, Fla., Oct. 02, 2025 (GLOBE NEW
BioStem Technologies, Inc. (BSEM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
06:15pm, Wednesday, 10'th Sep 2025
BioStem Technologies, Inc. (OTCPK:BSEM) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 3:20 PM EDT Company Participants Jason Matuszewski - CEO, President, Secretary & Chai
BioStem Showcasing its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Fall Meeting
12:34pm, Friday, 05'th Sep 2025
Company co-exhibiting with strategic partner Venture Medical, LLC, highlighting collaborative innovation in chronic wound care management Three scientific posters feature BioStem's proprietary allogra
BioStem Showcasing its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Fall Meeting
12:19pm, Friday, 05'th Sep 2025
Company co-exhibiting with strategic partner Venture Medical, LLC, highlighting collaborative innovation in chronic wound care management Three scientific posters feature BioStem's proprietary allogra
BioStem Technologies to Present at Two Upcoming Investor Conferences
08:58am, Tuesday, 02'nd Sep 2025
POMPANO BEACH, Fla., Sept. 02, 2025 – PRISM MediaWire – Press Release Service – Press Release Distribution – BioStem Technologies Inc.
BioStem Technologies to Present at Two Upcoming Investor Conferences
08:34am, Tuesday, 02'nd Sep 2025
POMPANO BEACH, Fla., Sept. 02, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-der
BioStem Technologies Announces Insider Share Purchase by Chairman and Chief Executive Officer
07:04am, Thursday, 21'st Aug 2025
POMPANO BEACH, FL, August 21, 2025 – PRISM MediaWire – BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placent
BioStem Technologies Announces Insider Share Purchase by Chairman and Chief Executive Officer
07:00am, Thursday, 21'st Aug 2025
POMPANO BEACH, Fla., Aug. 21, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-d
BioStem Technologies, Inc. (BSEM) Q2 2025 Earnings Call Transcript
08:55pm, Thursday, 14'th Aug 2025
BioStem Technologies, Inc. (OTCPK:BSEM) Q2 2025 Earnings Conference Call August 14, 2025 4:30 PM ET Company Participants Adam Holdsworth - Corporate Participant Brandon Poe - Corporate Participant Jas
BioStem Technologies Reports Preliminary Second Quarter 2025 Financial Results
04:17pm, Thursday, 14'th Aug 2025
POMPANO BEACH, FL, August 14, 2025 – PRISM MediaWire – BioStem Technologies, Inc. (“BioStem” or the “Company”) (OTC: BSEM), a leading MedTech company focused on the development, manufact
BioStem Technologies Appoints Brandon Poe as Chief Financial Officer
04:11pm, Thursday, 14'th Aug 2025
Seasoned healthcare CFO with senior experience in capital markets and financial operations across private and publicly traded companies to lead BioStem's financial team POMPANO BEACH, FL, August 14, 2
BioStem Technologies Reports Preliminary Second Quarter 2025 Financial Results
04:06pm, Thursday, 14'th Aug 2025
POMPANO BEACH, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (“BioStem” or the “Company”) (OTC: BSEM), a leading MedTech company focused on the development, manufacturing,
